RUO, IVD and LDT describe different concepts in laboratory testing. Learn what each term means, how they differ, and what laboratories should consider when evaluating molecular products.
800.676.5565 | [email protected]
01
Oct
Oct
Real-time PCR and next-generation sequencing answer different molecular questions. Compare target coverage, throughput, workflow complexity, data analysis and other considerations when choosing an approach for your laboratory.
28
Sep
Sep
The 2026–27 respiratory season is beginning. See how multiplex RT-PCR panels, extraction workflows and thoughtful target selection can help molecular laboratories prepare for changing respiratory research demands.
07
Nov
Nov
Wound and surgical site infections impact recovery and care. Learn key causes, risk factors, and modern tools that improve detection.
09
Jul
Jul
Urinary tract infections (UTIs) are among the most common bacterial infections, affecting millions of people each year in the United States. While they can occur in anyone, women are particularly susceptible due to anatomical differences, such as a shorter urethra that allows bacteria to reach the bladder more easily. Men, older adults, and individuals with […]
12
Jun
Jun
Sexually transmitted infections (STIs) are increasing at an alarming rate worldwide, posing significant public health concerns. Recent data shows that STI cases have surged in many regions, including the Americas and Africa1. Factors such as changing sexual behaviors, decreased condom use, and reduced access to healthcare services contribute to this rise. The increase underscores the […]
12
May
May
Antibiotic resistance is one of the most significant public health threats today. It occurs when bacteria evolve and become resistant to antibiotics that once killed them. This resistance develops due to the overuse and misuse of antibiotics, allowing bacteria to survive and multiply despite treatment. How Does Antibiotic Resistance Happen? Bacteria naturally adapt to their […]
28
Feb
Feb
Respiratory illnesses are surging across the U.S. As of February 21, 2025, the rate of acute respiratory illness leading individuals to seek healthcare remains at a high level, according to the CDC. Nearly 8% of outpatient visits are for flu-like symptoms, the highest flu activity in 15 years (CDC). A high level of acute respiratory […]
10
Feb
Feb
Respiratory viruses COVID-19, Influenza, and RSV share similar symptoms, making accurate testing essential. With current positivity rates for Influenza (31.6%), COVID-19 (4.8%), and RSV (6.8%) (CDC), broad testing helps distinguish between these infections and guide appropriate treatment. Symptoms and Risk Factors While these viruses share overlapping symptoms such as fever, cough, and shortness of breath, […]
13
Nov
Nov
AvertD is an FDA-approved genetic test that uses advanced scientific techniques to identify individuals at higher genetic risk for developing opioid use disorder (OUD)1. By analyzing DNA, the test detects 15 specific genetic polymorphisms that may be linked to an increased susceptibility to OUD, including variations in genes related to serotonin, dopamine, and opioid receptors […]